GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (FRA:LHU) » Definitions » Cyclically Adjusted Revenue per Share

LeMaitre Vascular (FRA:LHU) Cyclically Adjusted Revenue per Share : €6.53 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is LeMaitre Vascular Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

LeMaitre Vascular's adjusted revenue per share for the three months ended in Mar. 2024 was €2.180. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €6.53 for the trailing ten years ended in Mar. 2024.

During the past 12 months, LeMaitre Vascular's average Cyclically Adjusted Revenue Growth Rate was 8.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of LeMaitre Vascular was 10.80% per year. The lowest was 1.40% per year. And the median was 6.25% per year.

As of today (2024-06-14), LeMaitre Vascular's current stock price is €72.00. LeMaitre Vascular's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €6.53. LeMaitre Vascular's Cyclically Adjusted PS Ratio of today is 11.03.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of LeMaitre Vascular was 12.25. The lowest was 1.73. And the median was 6.89.


LeMaitre Vascular Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for LeMaitre Vascular's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LeMaitre Vascular Cyclically Adjusted Revenue per Share Chart

LeMaitre Vascular Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.24 3.92 5.03 5.77 6.26

LeMaitre Vascular Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.87 6.02 6.36 6.26 6.53

Competitive Comparison of LeMaitre Vascular's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Cyclically Adjusted PS Ratio falls into.



LeMaitre Vascular Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, LeMaitre Vascular's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.18/131.7762*131.7762
=2.180

Current CPI (Mar. 2024) = 131.7762.

LeMaitre Vascular Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.808 100.560 1.059
201409 0.767 100.428 1.006
201412 0.855 99.070 1.137
201503 0.984 99.621 1.302
201506 0.981 100.684 1.284
201509 0.916 100.392 1.202
201512 0.997 99.792 1.317
201603 0.965 100.470 1.266
201606 1.050 101.688 1.361
201609 1.075 101.861 1.391
201612 1.123 101.863 1.453
201703 1.145 102.862 1.467
201706 1.147 103.349 1.462
201709 1.034 104.136 1.308
201712 1.093 104.011 1.385
201803 1.045 105.290 1.308
201806 1.142 106.317 1.415
201809 1.020 106.507 1.262
201812 1.236 105.998 1.537
201903 1.247 107.251 1.532
201906 1.289 108.070 1.572
201909 1.297 108.329 1.578
201912 1.326 108.420 1.612
202003 1.353 108.902 1.637
202006 1.082 108.767 1.311
202009 1.510 109.815 1.812
202012 1.497 109.897 1.795
202103 1.446 111.754 1.705
202106 1.611 114.631 1.852
202109 1.487 115.734 1.693
202112 1.579 117.630 1.769
202203 1.625 121.301 1.765
202206 1.800 125.017 1.897
202209 1.774 125.227 1.867
202212 1.739 125.222 1.830
202303 1.974 127.348 2.043
202306 2.060 128.729 2.109
202309 1.976 129.860 2.005
202312 1.996 129.419 2.032
202403 2.180 131.776 2.180

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


LeMaitre Vascular  (FRA:LHU) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

LeMaitre Vascular's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=72.00/6.53
=11.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of LeMaitre Vascular was 12.25. The lowest was 1.73. And the median was 6.89.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


LeMaitre Vascular Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of LeMaitre Vascular's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


LeMaitre Vascular (FRA:LHU) Business Description

Traded in Other Exchanges
Address
63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

LeMaitre Vascular (FRA:LHU) Headlines

No Headlines